Kornitzer Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Sell |
325,646
-6,229
| -2% | -$338K | 0.39% | 57 |
|
|
2025
Q4 | $16.3M | Sell |
331,875
-11,099
| -3% | -$518K | 0.34% | 64 |
|
|
2025
Q3 | $14.8M | Sell |
342,974
-1,168
| -0.3% | -$45.6K | 0.3% | 79 |
|
|
2025
Q2 | $13.2M | Sell |
344,142
-5,809
| -2% | -$222K | 0.27% | 92 |
|
|
2025
Q1 | $13.6M | Buy |
349,951
+3,658
| +1% | +$134K | 0.28% | 89 |
|
|
2024
Q4 | $11.7M | Sell |
346,293
-13,874
| -4% | -$499K | 0.23% | 119 |
|
|
2024
Q3 | $14.7M | Buy |
360,167
+5,479
| +2% | +$224K | 0.27% | 102 |
|
|
2024
Q2 | $13.7M | Sell |
354,688
-1,415
| -0.4% | -$59.5K | 0.26% | 104 |
|
|
2024
Q1 | $15.3M | Sell |
356,103
-571
| -0.2% | -$23.5K | 0.28% | 105 |
|
|
2023
Q4 | $13.2M | Sell |
356,674
-58,853
| -14% | -$2.11M | 0.26% | 111 |
|
|
2023
Q3 | $15.1M | Sell |
415,527
-8,778
| -2% | -$312K | 0.31% | 84 |
|
|
2023
Q2 | $15.1M | Sell |
424,305
-99,871
| -19% | -$3.58M | 0.3% | 96 |
|
|
2023
Q1 | $18.7M | Sell |
524,176
-1,540
| -0.3% | -$53.9K | 0.37% | 73 |
|
|
2022
Q4 | $18.5M | Sell |
525,716
-13,779
| -3% | -$459K | 0.37% | 72 |
|
|
2022
Q3 | $15.9M | Sell |
539,495
-18,323
| -3% | -$694K | 0.34% | 78 |
|
|
2022
Q2 | $30.4M | Sell |
557,818
-4,085
| -0.7% | -$226K | 0.61% | 34 |
|
|
2022
Q1 | $30.6M | Sell |
561,903
-4,001
| -0.7% | -$217K | 0.5% | 48 |
|
|
2021
Q4 | $31.2M | Sell |
565,904
-4,694
| -0.8% | -$244K | 0.47% | 53 |
|
|
2021
Q3 | $27.3M | Sell |
570,598
-1,574
| -0.3% | -$79.1K | 0.42% | 68 |
|
|
2021
Q2 | $28.5M | Sell |
572,172
-82,802
| -13% | -$3.98M | 0.43% | 65 |
|
|
2021
Q1 | $29.2M | Buy |
654,974
+3,769
| +0.6% | +$171K | 0.47% | 61 |
|
|
2020
Q4 | $30M | Sell |
651,205
-34,353
| -5% | -$1.58M | 0.51% | 56 |
|
|
2020
Q3 | $32.3M | Sell |
685,558
-7,336
| -1% | -$368K | 0.63% | 32 |
|
|
2020
Q2 | $35.3M | Buy |
692,894
+1,235
| +0.2% | +$63.4K | 0.71% | 26 |
|
|
2020
Q1 | $32.8M | Sell |
691,659
-16,215
| -2% | -$865K | 0.78% | 24 |
|
|
2019
Q4 | $41.6M | Sell |
707,874
-100,292
| -12% | -$5.58M | 0.73% | 26 |
|
|
2019
Q3 | $43.1M | Sell |
808,166
-5,400
| -0.7% | -$278K | 0.78% | 24 |
|
|
2019
Q2 | $40.7M | Buy |
813,566
+3,556
| +0.4% | +$178K | 0.72% | 28 |
|
|
2019
Q1 | $42.3M | Sell |
810,010
-84,010
| -9% | -$4.2M | 0.76% | 25 |
|
|
2018
Q4 | $42.7M | Sell |
894,020
-6,972
| -0.8% | -$343K | 0.85% | 21 |
|
|
2018
Q3 | $45.2M | Buy |
900,992
+1,695
| +0.2% | +$86.1K | 0.72% | 26 |
|
|
2018
Q2 | $45.3M | Buy |
899,297
+2,305
| +0.3% | +$116K | 0.76% | 24 |
|
|
2018
Q1 | $43.8M | Buy |
896,992
+25,956
| +3% | +$1.21M | 0.75% | 25 |
|
|
2017
Q4 | $38.6M | Sell |
871,036
-68,507
| -7% | -$3.16M | 0.66% | 35 |
|
|
2017
Q3 | $47.7M | Sell |
939,543
-25,992
| -3% | -$1.32M | 0.83% | 26 |
|
|
2017
Q2 | $52M | Sell |
965,535
-23,951
| -2% | -$1.28M | 0.91% | 16 |
|
|
2017
Q1 | $52.1M | Buy |
989,486
+15,194
| +2% | +$771K | 0.93% | 19 |
|
|
2016
Q4 | $46.9M | Sell |
974,292
-11,128
| -1% | -$550K | 0.88% | 24 |
|
|
2016
Q3 | $53.1M | Buy |
985,420
+7,280
| +0.7% | +$399K | 0.95% | 16 |
|
|
2016
Q2 | $53M | Buy |
978,140
+13,484
| +1% | +$710K | 0.96% | 16 |
|
|
2016
Q1 | $48.9M | Buy |
964,656
+10,553
| +1% | +$526K | 0.84% | 21 |
|
|
2015
Q4 | $48.1M | Buy |
954,103
+1,536
| +0.2% | +$78.3K | 0.79% | 21 |
|
|
2015
Q3 | $45.8M | Buy |
952,567
+40,836
| +4% | +$2.13M | 0.73% | 24 |
|
|
2015
Q2 | $47.5M | Buy |
911,731
+9,271
| +1% | +$522K | 0.64% | 42 |
|
|
2015
Q1 | $52.1M | Buy |
902,460
+16,804
| +2% | +$963K | 0.63% | 50 |
|
|
2014
Q4 | $47.3M | Buy |
885,656
+113,872
| +15% | +$6.37M | 0.55% | 64 |
|
|
2014
Q3 | $44.3M | Buy |
771,784
+95,308
| +14% | +$5.84M | 0.51% | 70 |
|
|
2014
Q2 | $45.2M | Buy |
676,476
+9,604
| +1% | +$650K | 0.49% | 72 |
|
|
2014
Q1 | $44.5M | Buy |
666,872
+13,920
| +2% | +$941K | 0.47% | 71 |
|
|
2013
Q4 | $43.6M | Buy |
652,952
+6,664
| +1% | +$432K | 0.47% | 70 |
|
|
2013
Q3 | $40.5M | Sell |
646,288
-520
| -0.1% | -$33.5K | 0.47% | 71 |
|
|
2013
Q2 | $40.4M | Buy |
+646,808
| New | +$41.1M | 0.53% | 63 |
|
Other funds holding GSK
JEST